Mar 4, 2026 06:01AM

Mar 3, 2026 09:54AM

Mar 3, 2026 07:30AM

Mar 3, 2026 04:56AM

Mar 2, 2026 03:25PM

Mar 2, 2026 02:48PM

Mar 2, 2026 02:18PM Intellia Therapeutics (NTLA) PT Raised to $27 at Chardan

Mar 2, 2026 02:04PM

Mar 2, 2026 12:28PM

Mar 2, 2026 12:05PM

Mar 2, 2026 10:25AM

Mar 2, 2026 10:04AM

Feb 26, 2026 01:31PM

Feb 26, 2026 01:28PM TD Cowen Reiterates Buy Rating on Intellia Therapeutics (NTLA)

Feb 26, 2026 07:35AM

Jan 28, 2026 06:39AM

Jan 27, 2026 11:29AM

Dec 19, 2025 09:06AM

Nov 11, 2025 04:31PM

Nov 11, 2025 07:17AM

Nov 11, 2025 03:20AM Evercore ISI Downgrades Intellia Therapeutics (NTLA) to In Line

Nov 7, 2025 08:56AM

Nov 7, 2025 04:48AM

Nov 7, 2025 03:50AM

Nov 6, 2025 04:29PM

Oct 31, 2025 09:54AM

Oct 31, 2025 07:27AM

Oct 30, 2025 04:55AM Intellia Therapeutics (NTLA) PT Lowered to $9 at Baird

Oct 29, 2025 04:24PM

Oct 28, 2025 06:41AM

Oct 28, 2025 06:26AM

Oct 28, 2025 04:23AM

Oct 28, 2025 03:30AM

Oct 28, 2025 03:30AM

Oct 28, 2025 03:29AM RBC Capital Downgrades Intellia Therapeutics (NTLA) to Sector Perform

Oct 27, 2025 02:17PM

Oct 27, 2025 10:23AM

Oct 27, 2025 09:41AM

Oct 27, 2025 07:59AM

Oct 27, 2025 07:31AM

Oct 6, 2025 02:18AM

Sep 19, 2025 06:48AM Intellia Therapeutics (NTLA) PT Raised to $30 at H.C. Wainwright

Sep 19, 2025 04:40AM

Aug 30, 2025 04:00PM

Aug 15, 2025 12:41PM

Aug 13, 2025 07:08AM

Aug 8, 2025 06:29AM

Aug 8, 2025 06:24AM

Aug 7, 2025 07:33AM Intellia Therapeutics (NTLA) Tops Q2 EPS by 5c

Jun 18, 2025 12:15PM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All